Status:
COMPLETED
Amino Acid Therapy for Hot Flashes in Postmenopausal Women
Lead Sponsor:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
Hot Flashes
Eligibility:
FEMALE
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to determine the safety, tolerability, and effectiveness of the amino acid L-isoleucine in the treatment of hot flashes in postmenopausal women.
Detailed Description
Hot flashes affect approximately 75% of postmenopausal women. Although hormone replacement therapy (HRT) is highly effective in reducing hot flashes, long-term HRT is associated with increased rates o...
Eligibility Criteria
Inclusion
- Postmenopausal
- Experience over 5 hot flashes per day
Exclusion
- Hormone Replacement Therapy (HRT) in the past 2 months
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00081952
Start Date
October 1 2003
End Date
October 1 2007
Last Update
March 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Health Initiative
Buffalo, New York, United States, 14214